Skip to content
Fast Company Executive Board

The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience.

The promise of proactive healthcare

Spend less and live longer, healthier lives.

[Photo: Getty Images]

Profile photo of Jay Bhatt

Managing Director of the Deloitte Center for Health Solutions · Deloitte

As a physician, I have seen firsthand how the current, reactive healthcare model often leads to costly interventions after conditions have advanced. This cycle can change. The U.S. spends nearly $5 trillion a year on healthcare, with Medicare accounting for more than $1 trillion. Proactive measures could cut costs by $2.2 trillion every year, with $500 billion in annual savings for Medicare alone.

Today, Americans live an average of 77.9 years, but only about 85% of those years are spent in good health. By emphasizing prevention and proactive care, we believe it is possible for more people to enjoy not just longer lifespans, but healthier lives—all while spending less overall on healthcare over their lifetimes. Our Deloitte actuarial analysis suggests that an increased focus on early detection and prevention could increase the average U.S. lifespan by 12 years and health span by nearly 20 years.

THE RISE IN HOME MONITORING

Most healthcare happens outside of medical facilities. Americans spend our lives at work, at home, and with family. Innovations such as home diagnostics and wearable devices have made it possible to detect some diseases before symptoms arise. This is more than a matter of convenience; it is a fundamental shift in how and when health challenges are identified and addressed. By moving diagnostics and monitoring devices into the home, individuals gain greater control over their health, and clinicians can intervene earlier, preventing future complications and keeping patients healthier longer.

Consider these hypothetical clinical examples:

  • An 82-year-old man receives a home blood test. Early detection of abnormal kidney function allows for proactive intervention, enabling him to avoid dialysis and hospitalization.
  • A 68-year-old’s wearable device detects a possible lung abnormality. Subsequent screening confirms a stage-one tumor, which is removed in an outpatient procedure, preventing more costly and intensive treatments in the future.

INVESTMENT IN PREVENTION

By investing in prevention, screening, and healthy living, people can delay onset and lessen the severity of some illnesses, potentially saving more than $125 billion on heart disease alone. The potential benefits of proactive healthcare investments vary widely by disease state. For example, Deloitte’s actuarial estimates indicate that by 2024, U.S. spending on cancer could reach $1.1 trillion. That number can be decreased by taking a more personalized, prevention-focused, and proactive approach, according to our Deloitte Future of Health framework. The same holds for kidney disease and other chronic conditions. Chronic conditions tend to drive most healthcare expenses, but preventing or managing conditions early can help avoid costly complications.

Preventive care and early detection are important, but eating healthier can also drive down healthcare costs. According to our consumer data, the majority of Americans—including those surveyed with chronic illness—prefer focusing on good nutrition to manage their health. Evidence shows that medically tailored meals for Medicare beneficiaries can reduce hospitalizations and generate billions in net savings.

The prevention and early detection of disease do more than delay costs—they can reduce spending, improve longevity, and enhance quality of life.

Focusing on proactive care can reduce healthcare costs by trillions while improving health outcomes for millions of Americans. Prevention, early detection, and healthy habits—including nutrition, diet, and home diagnostics—can help Americans add more healthy years to their lives.

The author acknowledges the contributions of Kulleni Gebreyes, MD, Deloitte vice chair and U.S. life sciences and health care industry leader, to this article.

Jay Bhatt, DO is managing director, Deloitte Services LP.